{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:45:02Z","timestamp":1791233102353,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2004,7,13]],"date-time":"2004-07-13T00:00:00Z","timestamp":1089676800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1038\/sj.bjc.6602026","type":"journal-article","created":{"date-parts":[[2004,7,14]],"date-time":"2004-07-14T05:08:35Z","timestamp":1089781715000},"page":"607-612","source":"Crossref","is-referenced-by-count":132,"title":["Role of urothelial cells in BCG immunotherapy for superficial bladder cancer"],"prefix":"10.1038","volume":"91","author":[{"given":"R F M","family":"Bevers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K-H","family":"Kurth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D H J","family":"Schamhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,7,13]]},"reference":[{"key":"BF6602026_CR1","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/S0140-6736(98)07422-4","volume":"353","author":"AB Alexandroff","year":"1999","unstructured":"Alexandroff AB, Jackson AM, O'Donnell MA, James K (1999) BCG immunotherapy of bladder cancer: 20 years on. Lancet 353: 1689\u20131694","journal-title":"Lancet"},{"key":"BF6602026_CR2","first-page":"181","volume":"9","author":"RFM Bevers","year":"1998","unstructured":"Bevers RFM, de Boer EC, Kurth K-H, Schamhart DHJ (1998) BCG-induced interleukin-6 upregulation and BCG internalization in well and poorly differentiated human bladder cancer cell lines. Eur Cytokine Network 9: 181\u2013186","journal-title":"Eur Cytokine Network"},{"issue":"Suppl 1","key":"BF6602026_CR3","first-page":"31","volume":"31","author":"RFM Bevers","year":"2000","unstructured":"Bevers RFM, de Boer EC, Kurth K-H, Schamhart DHJ (2000) BCG internalization in human bladder cancer cell lines, especially with regard to cell surface-expressed fibronectin. Aktuelle Urol 31 (Suppl 1): 31\u201334","journal-title":"Aktuelle Urol"},{"key":"BF6602026_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/BF00941903","volume":"25","author":"EC Boer de","year":"1997","unstructured":"Boer de EC, Somogyi L, de Ruiter GJ, de Reijke TM, Kurth KH, Schamhart DH (1997) Role of interleukin-8 in onset of the immune response in intravesical BCG therapy for superficial bladder cancer. Urol Res 25: 31\u201334","journal-title":"Urol Res"},{"key":"BF6602026_CR5","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/1097-0215(20010601)92:5<697::AID-IJC1245>3.0.CO;2-Z","volume":"92","author":"S Brandau","year":"2001","unstructured":"Brandau S, Riemensberger J, Jacobsen M, Kemp D, Zhao W, Zhao X, Jocham D, Ratliff TL, B\u00f6hle A (2001) NK cells are essential for the effective BCG immunotherapy. Int J Cancer 92: 697\u2013702","journal-title":"Int J Cancer"},{"key":"BF6602026_CR6","first-page":"542","volume":"10","author":"D Champetier","year":"2000","unstructured":"Champetier D, Valignat C, Lopez JG, Ruffion A, Devonec M, Perrin P (2000) Intravesical BCG-therapy: comparison of side effects of Connaught (Toronto) and Pasteur (Paris) strains [Article in French]. Prog Urol 10: 542\u2013547","journal-title":"Prog Urol"},{"key":"BF6602026_CR7","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1097\/01.ju.0000091826.83705.79","volume":"170","author":"EC De Boer","year":"2003","unstructured":"De Boer EC, Rooijakkers SJ, Schamhart DH, Kurth KH (2003) Cytokine gene expression in a mouse model: the first instillations with viable bacillus Calmette-Guerin determine the succeeding Th1 response. J Urol 170: 2004\u20132008","journal-title":"J Urol"},{"key":"BF6602026_CR8","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/S0161-5890(02)00210-9","volume":"39","author":"S Diehl","year":"2002","unstructured":"Diehl S, Rincon M (2002) The two faces of IL-6 on Th1\/Th2 differentiation. Mol Immunol 39: 531\u2013536","journal-title":"Mol Immunol"},{"key":"BF6602026_CR9","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/S0022-5347(05)68633-8","volume":"162","author":"C Durek","year":"1999","unstructured":"Durek C, Brandau S, Ulmer AJ, Flad HD, Jocham D, B\u00f6hle A (1999) Bacillus-Calmette-Gu\u00e9rin (BCG) and 3D tumors: an in vitro model for the study of adhesion and invasion. J Urol 162: 600\u2013605","journal-title":"J Urol"},{"key":"BF6602026_CR10","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1097\/00005392-199907000-00072","volume":"162","author":"D Fontana","year":"1999","unstructured":"Fontana D, Bellina M, Galietti F, Scoffone C, Cagnazzi E, Guercio S, Cappia S, Pozzi E (1999) Intravesical Bacillus Calmette-Gu\u00e9rin (BCG) as inducer of tumor suppressing proteins p53 and p21Waf1-Cip1 during treatment of superficial bladder cancer. J Urol 162: 225\u2013230","journal-title":"J Urol"},{"key":"BF6602026_CR11","first-page":"3726","volume":"51","author":"MA Hudson","year":"1991","unstructured":"Hudson MA, Brown EJ, Ritchey JK, Ratliff TL (1991) Modulation of fibronectin-mediated Bacillus Calmette-Gu\u00e9rin attachment to murine bladder mucosa by drugs influencing the coagulation pathways. Cancer Res 51: 3726\u20133732","journal-title":"Cancer Res"},{"key":"BF6602026_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1046\/j.1442-2042.2002.00415.x","volume":"9","author":"N Ikeda","year":"2002","unstructured":"Ikeda N, Toida I, Iwasaki A, Kawai K, Akaza H (2002) Surface antigen expression on bladder tumor cells induced by bacillus Calmette-Gu\u00e9rin (BCG): a role of BCG internalization into tumor cells. Int J Urol 9: 29\u201335","journal-title":"Int J Urol"},{"key":"BF6602026_CR13","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1136\/jcp.47.4.309","volume":"47","author":"AM Jackson","year":"1994","unstructured":"Jackson AM, Alexandroff AB, McIntyre M, Esuvaranathan K, James K, Chisholm GD (1994) Induction of ICAM 1 expression on bladder tumors by BCG immunotherapy. J Clin Pathol 47: 309\u2013312","journal-title":"J Clin Pathol"},{"key":"BF6602026_CR14","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/bjc.1998.545","volume":"78","author":"OT Jansson","year":"1998","unstructured":"Jansson OT, Morcos E, Brundin L, Lundberg JO, Adolfsson J, Soderhall M, Wiklund NP (1998) The role of nitric oxide in bacillus Calmette-Gu\u00e9rin mediated anti-tumor effects in human bladder cancer. Br J Cancer 78: 588\u2013592","journal-title":"Br J Cancer"},{"key":"BF6602026_CR15","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1126\/science.7863341","volume":"267","author":"K K\u00e4rre","year":"1995","unstructured":"K\u00e4rre K (1995) Express yourself or die: Peptides, MHC molecules and NK cells. Science 267: 978\u2013979","journal-title":"Science"},{"key":"BF6602026_CR16","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1172\/JCI114434","volume":"85","author":"LR Kavoussi","year":"1990","unstructured":"Kavoussi LR, Brown EJ, Ritchey JK, Ratliff TL (1990) Fibronectin-mediated Calmette-Gu\u00e9rin bacillus attachment to murine bladder mucosa. Requirement for the expression of an antitumor response. J Clin Invest 85: 62\u201367","journal-title":"J Clin Invest"},{"key":"BF6602026_CR17","doi-asserted-by":"publisher","first-page":"5345","DOI":"10.4049\/jimmunol.170.11.5345","volume":"170","author":"T Kawashima","year":"2003","unstructured":"Kawashima T, Norose Y, Watanabe Y, Enomoto Y, Narazaki H, Watari E, Tanaka S, Takahashi H, Yano I, Brenner MB, Sugita M (2003) Cutting edge: major CD8 T cell response to live bacillus Calmette-Gu\u00e8rin is mediated by CD1 molecules. J Immunol 170: 5345\u20135348","journal-title":"J Immunol"},{"issue":"Suppl 3","key":"BF6602026_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000052386","volume":"37","author":"KH Kurth","year":"2000","unstructured":"Kurth KH, Bouffioux C, Sylvester R, van der Meijden AP, Oosterlinck W, Brausi M (2000) Treatment of superficial bladder tumors: achievements and needs The EORTC Genitourinary Group. Eur Urol 37 (Suppl 3): 1\u20139","journal-title":"Eur Urol"},{"key":"BF6602026_CR19","first-page":"4286","volume":"52","author":"EC Lattime","year":"1992","unstructured":"Lattime EC, Gomella LG, McCue P (1992) Murine bladder carcinoma cells present antigen to BCG-specific CD4+ T-cells. Cancer Res 52: 4286\u20134290","journal-title":"Cancer Res"},{"key":"BF6602026_CR20","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1002\/cncr.11072","volume":"97","author":"VM Lauta","year":"2003","unstructured":"Lauta VM (2003) A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications. Cancer 97: 2440\u20132452","journal-title":"Cancer"},{"key":"BF6602026_CR21","first-page":"241","volume":"43","author":"SJ Levine","year":"1995","unstructured":"Levine SJ (1995) Bronchial epithelial cell\u2013cytokine interactions in airway inflammation. J Invest Med 43: 241\u2013249","journal-title":"J Invest Med"},{"key":"BF6602026_CR22","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S1286-4579(00)00268-9","volume":"2","author":"WP Maksymowych","year":"2000","unstructured":"Maksymowych WP, Kane KP (2000) Bacterial modulation of antigen processing and presentation. Microb Infect 2: 199\u2013211","journal-title":"Microb Infect"},{"key":"BF6602026_CR23","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/S0022-5347(17)36197-9","volume":"149","author":"MD Melekos","year":"1993","unstructured":"Melekos MD, Chionis H, Pantazakos A, Fokaefs E, Paranychianakis G, Dauaher H (1993) Intravesical bacillus Calmette-Gu\u00e9rin immunoprophylaxis of superficial bladder cancer: results of a controlled prospective trial with modified treatment schedule. J Urol 149: 744\u2013748","journal-title":"J Urol"},{"key":"BF6602026_CR24","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1016\/S0022-5347(05)65642-X","volume":"166","author":"A Morales","year":"2001","unstructured":"Morales A, Chin JL, Ramsey EW (2001) Mycobacterial cell wall extract for the treatment of carcinoma in situ of the bladder. J Urol 166: 1633\u20131638","journal-title":"J Urol"},{"key":"BF6602026_CR25","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1046\/j.1365-2249.2003.02071.x","volume":"131","author":"R Nadler","year":"2003","unstructured":"Nadler R, Luo Y, Zhao W, Ritchey JK, Austin JC, Cohen MB, O'Donnell MA, Ratliff TL (2003) Interleukin 10 induced augmentation of delayed-type hypersensitivity (DTH) enhances Mycobacterium bovis bacillus Calmette-Gu\u00e9rin (BCG) mediated antitumor activity. Clin Exp Immunol 131: 206\u2013216","journal-title":"Clin Exp Immunol"},{"key":"BF6602026_CR26","doi-asserted-by":"publisher","first-page":"447","DOI":"10.4049\/jimmunol.166.1.447","volume":"166","author":"O Neyrolles","year":"2001","unstructured":"Neyrolles O, Gould K, Gares MP, Brett S, Janssen R, O'Gaora P, Herrmann JL, Prevost MC, Perret E, Thole JE, Young D (2001) Lipoprotein access to MHC class I presentation during infection of murine macrophages with live mycobacteria. J Immunol 166: 447\u2013457","journal-title":"J Immunol"},{"key":"BF6602026_CR27","first-page":"1762","volume":"47","author":"TL Ratliff","year":"1987","unstructured":"Ratliff TL, Palmer JO, McGarr JA, Brown EJ (1987) Intravesical Bacillus Calmette-Gu\u00e9rin therapy for murine bladder tumors: initiation of the response by fibronectin-mediated attachment of Bacillus Calmette-Gu\u00e9rin. Cancer Res 47: 1762\u20131766","journal-title":"Cancer Res"},{"key":"BF6602026_CR28","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1046\/j.1464-410X.2001.02394.x","volume":"88","author":"F Saint","year":"2001","unstructured":"Saint F, Patard JJ, Groux Muscatelli B, Lefefre Belda MA, Gil Diez de Medina S, Abbou CC, Chopin DK (2001) Evaluation of cellular tumor rejection mechanisms in the peritumoral bladder wall after bacillus Calmette-Gu\u00e9rin treatment. BJU Int 88: 602\u2013610","journal-title":"BJU Int"},{"key":"BF6602026_CR29","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1055\/s-2007-1001917","volume":"20","author":"DH Schamhart","year":"1994","unstructured":"Schamhart DH, De Boer EC, Vleeming R, Kurth KH (1994) Theoretical and experimental evidence on the use of glycosaminoglycans in BCG-mediated immunotherapy of superficial bladder cancer. Semin Thromb Hemost 20: 301\u2013309","journal-title":"Semin Thromb Hemost"},{"key":"BF6602026_CR30","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/BF00184116","volume":"12","author":"B Schneider","year":"1994","unstructured":"Schneider B, Thanhauser A, Jocham D, Loppnow H, Vollmer E, Galle J, Flad HD, Ulmer AJ, B\u00f6hle A (1994) Specific binding of bacillus Calmette-Gu\u00e9rin to urothelial tumor cells in vitro. World J Urol 12: 337\u2013344","journal-title":"World J Urol"},{"key":"BF6602026_CR31","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.4049\/jimmunol.164.9.4790","volume":"164","author":"PA Sieling","year":"2000","unstructured":"Sieling PA, Ochoa MT, Jullien D, Leslie DS, Sabet S, Rosat JP, Burdick AE, Rea TH, Brenner MB, Porcelli SA, Modlin RL (2000) Evidence for human CD4+ T cells in the CD1-restricted repertoire: derivation of mycobacteria-reactive T cells from leprosy lesions. J Immunol 164: 4790\u20134796","journal-title":"J Immunol"},{"key":"BF6602026_CR32","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/BF00299721","volume":"20","author":"JS Teppema","year":"1992","unstructured":"Teppema JS, de Boer EC, Steerenberg PA, van der Meijden AP (1992) Morphological aspects of the interaction of Bacillus Calmette-Gu\u00e9rin with urothelial bladder cells in vivo and in vitro: relevance for antitumor activity? Urol Res 20: 219\u2013228","journal-title":"Urol Res"},{"issue":"Suppl 1","key":"BF6602026_CR33","first-page":"10","volume":"14","author":"WP Witjes","year":"1996","unstructured":"Witjes WP, Witjes JA, Oosterhof GO, Debruyne MJ (1996) Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Tice-Tice versus bacillus Calmette-Gu\u00e9rin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group. Semin Urol Oncol 14 (Suppl 1): 10\u201316","journal-title":"Semin Urol Oncol"},{"key":"BF6602026_CR34","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/S0022-5347(05)67417-4","volume":"164","author":"H Yamada","year":"2000","unstructured":"Yamada H, Matsumoto S, Matsumoto T, Yamada T, Yamashita U (2000) Murine IL-2 secreting recombinant Bacillus Calmette-Gu\u00e8rin augments macrophage-mediated cytotoxicity against murine bladder cancer MBT-2. J Urol 164: 526\u2013531","journal-title":"J Urol"},{"key":"BF6602026_CR35","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/(SICI)1097-0215(20000401)86:1<83::AID-IJC13>3.0.CO;2-R","volume":"86","author":"W Zhao","year":"2000","unstructured":"Zhao W, Schorey JS, Bong-Mastek M, Ritchey J, Brown EJ, Ratliff TL (2000) Role of a bacillus Calmette-Gu\u00e9rin fibronectin attachment protein in BCG-induced antitumor activity. Int J Cancer 86: 83\u201388","journal-title":"Int J Cancer"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6602026.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6602026","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6602026.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T08:10:50Z","timestamp":1684397450000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6602026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7,13]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["BF6602026"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6602026","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7,13]]}}}